TY  - JOUR
AU  - M Nezami
PY  - 2025
DA  - 2025/06/19
TI  - Selective and Adaptive Targeted Approach to Influence Genomics and Epigenomic Signature in Lung Cancer
JO  - Case Reports and Reviews
VL  - 5
IS  - 3
AB  - Application of single targeted therapies in cancer has caused resistance in tumors, especially the
heterogeneous tumors such as lung cancer. Here we propose a different strategy in approaching
heterogeneous tumors, looking at a sequential but systemic and pan-genomic targeted therapy through
epigenetic modifications. We aim to trigger new hypotheses and generate provoking scientific methods
to address current challenges in oncology care.
SN  - 2693-1516
UR  - https://dx.doi.org/10.33425/2693-1516.1055
DO  - 10.33425/2693-1516.1055